Pittsburgh Business Times Names invivodata to 2008 Pittsburgh 100
PITTSBURGH, Aug. 25 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that the Pittsburgh Business Times has recognized the company in the "2008 Pittsburgh 100" annual ranking of the fastest-growing, privately-held companies in Western Pennsylvania.
"We see the Pittsburgh 100 as one of the most important lists we publish," said Alan Robertson, publisher of the Pittsburgh Business Times. "The companies on this list represent many industries and many geographic locations around the region. The Pittsburgh 100 companies also represent all different sizes of companies, from small firms to multi-billion dollar operations. We see the Pittsburgh 100 as proof that the region remains a vibrant, growth-oriented business environment."
Rankings on the list were based on the rate of growth from 2005 through 2007. Honored at an awards program at the Duquesne Club in downtown Pittsburgh on August 21, invivodata was ranked the 10th fastest-growing technology company and #43 overall on the list of 100, based on revenue growth.
"We're very proud to be included in the Pittsburgh 100," said Doug Engfer, invivodata president and CEO. "We believe our inclusion in the list is representative of the consistent results we are delivering to our new and existing customers, and the growing demand for our ePRO solutions and expertise."
About invivodata inc.
invivodata combines behavioral science, information technology, and
clinical research expertise to capture high quality clinical trial data
directly from patients. invivodata's electronic Patient Reported Outcomes
(ePRO) solutions, which are based on over 20 years of research, deliver
reliable patient self-reported data by driving patient compliance with the
protocol and eliminating recall biases that plague paper-based self-report
data. invivodata's solutions include comprehensive trial-support services
that facilitate the collection of ePRO data, and web-based access to study
data and operational reports that give researchers and sponsors visibility
into study progress and improve trial efficiencies. invivodata's solution
has been used in more than 200 trials and is the industry-leading ePRO
system in delivering primary efficacy data for FDA drug approvals.
invivodata inc. is a privately held company with global headquarters in
Pittsburgh, Pa., USA; its European headquarters is in London, England; and
its technology development center is in Scotts Valley, Calif., USA. For
more information visit http://www.invivodata.com/.
For more information, contact:
Corporate Communications Specialist
(412) 390-3000, ext. 3502
|SOURCE invivodata inc.|
Copyright©2008 PR Newswire.
All rights reserved